ArticleJournal of acquired immune deficiency syndromes (1999)2023
Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine.
Kristina M Brooks et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.